GUIDELINES FOR MANAGEMENT OF CHILDREN WITH CYSTIC FIBROSIS
AbstractBACKGROUND Cystic fibrosis is the most common autosomal recessive hereditary disease. The clinicalconsequences include multisystem disease characterised by progressive pulmonary disease leading to respiratory failure, pancreatic disfunction, liver disease that may progressto chirrhosis and men infertility due to atresia of the vas deferens. Early intervention andprevention of lung disease is of paramount importance, since the prognosis of the diseaseis substantially dependent on chronic respiratory infection and inflammation. Cysticfibrosis is a complex disease requiring a multidisciplinary approach to treatment. Centercare by a team of experienced health professionals is essential for optimal patient management and outcome. CONCLUSIONS The article presents diagnostic and therapeutic recommendations for the management of children with cystic fibrosi
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.